Multisocietal European consensus on the terminology, diagnosis, and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE

Other authors

Institut Català de la Salut

[Siriwardena AK] Hepato-Pancreato-Biliary Unit, Manchester Royal Infirmary, Manchester, UK. [Serrablo A] Department of Surgery, Miguel Servet University Hospital, Zaragoza, Spain. [Fretland ÅA] Department of Surgery, Oslo University Hospital, Oslo, Norway. [Wigmore SJ] Hepatobiliary and Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, UK. [Ramia-Angel JM] Department of Surgery, University Hospital of Guadalajara, Guadalajara, Spain. [Malik HZ] Liver Surgery Unit, Royal Liverpool University Hospital, Liverpool, UK. [Pellino G] Unitat de Cirurgia de Còlon i Recte, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania ‘Luigi Vanvitelli’, Naples, Italy

Vall d'Hebron Barcelona Hospital Campus

Publication date

2023-08-23T07:00:27Z

2023-08-23T07:00:27Z

2023-08-11



Abstract

Consensus; Colorectal cancer; Liver metastases


Consens; Càncer colorectal; Metàstasis hepàtiques


Consenso; Cáncer colorrectal; Metástasis hepáticas


Background Contemporary management of patients with synchronous colorectal cancer and liver metastases is complex. The aim of this project was to provide a practical framework for care of patients with synchronous colorectal cancer and liver metastases, with a focus on terminology, diagnosis, and management. Methods This project was a multiorganizational, multidisciplinary consensus. The consensus group produced statements which focused on terminology, diagnosis, and management. Statements were refined during an online Delphi process, and those with 70 per cent agreement or above were reviewed at a final meeting. Iterations of the report were shared by electronic mail to arrive at a final agreed document comprising 12 key statements. Results Synchronous liver metastases are those detected at the time of presentation of the primary tumour. The term ‘early metachronous metastases' applies to those absent at presentation but detected within 12 months of diagnosis of the primary tumour, the term ‘late metachronous metastases’ applies to those detected after 12 months. ‘Disappearing metastases’ applies to lesions that are no longer detectable on MRI after systemic chemotherapy. Guidance was provided on the recommended composition of tumour boards, and clinical assessment in emergency and elective settings. The consensus focused on treatment pathways, including systemic chemotherapy, synchronous surgery, and the staged approach with either colorectal or liver-directed surgery as first step. Management of pulmonary metastases and the role of minimally invasive surgery was discussed. Conclusion The recommendations of this contemporary consensus provide information of practical value to clinicians managing patients with synchronous colorectal cancer and liver metastases.

Document Type

Article


Published version

Language

English

Publisher

Oxford University Press

Related items

British Journal of Surgery;110(9)

https://doi.org/10.1093/bjs/znad124

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)